Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis
Abstract Background Inflammatory osteolysis, a major complication of total joint replacement surgery, can cause prosthesis failure and necessitate revision surgery. Macrophages are key effector immune cells in inflammatory responses, but excessive M1-polarization of dysfunctional macrophages leads t...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b1124ab7b22439f9b6250b3c632546b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9b1124ab7b22439f9b6250b3c632546b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9b1124ab7b22439f9b6250b3c632546b2021-11-28T12:26:41ZMacrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis10.1186/s12951-021-01128-41477-3155https://doaj.org/article/9b1124ab7b22439f9b6250b3c632546b2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12951-021-01128-4https://doaj.org/toc/1477-3155Abstract Background Inflammatory osteolysis, a major complication of total joint replacement surgery, can cause prosthesis failure and necessitate revision surgery. Macrophages are key effector immune cells in inflammatory responses, but excessive M1-polarization of dysfunctional macrophages leads to the secretion of proinflammatory cytokines and severe loss of bone tissue. Here, we report the development of macrophage-biomimetic porous SiO2-coated ultrasmall Se particles (porous Se@SiO2 nanospheres) to manage inflammatory osteolysis. Results Macrophage membrane-coated porous Se@SiO2 nanospheres(M-Se@SiO2) attenuated lipopolysaccharide (LPS)-induced inflammatory osteolysis via a dual-immunomodulatory effect. As macrophage membrane decoys, these nanoparticles reduced endotoxin levels and neutralized proinflammatory cytokines. Moreover, the release of Se could induce macrophage polarization toward the anti-inflammatory M2-phenotype. These effects were mediated via the inhibition of p65, p38, and extracellular signal-regulated kinase (ERK) signaling. Additionally, the immune environment created by M-Se@SiO2 reduced the inhibition of osteogenic differentiation caused by proinflammation cytokines, as confirmed through in vitro and in vivo experiments. Conclusion Our findings suggest that M-Se@SiO2 have an immunomodulatory role in LPS-induced inflammation and bone remodeling, which demonstrates that M-Se@SiO2 are a promising engineered nanoplatform for the treatment of osteolysis occurring after arthroplasty. Graphical AbstractCheng DingChuang YangTao ChengXingyan WangQiaojie WangRenke HeShang SangKechao ZhuDongdong XuJiaxing WangXijian LiuXianlong ZhangBMCarticleBiomimetic nanoparticlePorous Se@SiO2 nanospheresMacrophage polarizationOsteolysisImmunomodulationBiotechnologyTP248.13-248.65Medical technologyR855-855.5ENJournal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-16 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Biomimetic nanoparticle Porous Se@SiO2 nanospheres Macrophage polarization Osteolysis Immunomodulation Biotechnology TP248.13-248.65 Medical technology R855-855.5 |
spellingShingle |
Biomimetic nanoparticle Porous Se@SiO2 nanospheres Macrophage polarization Osteolysis Immunomodulation Biotechnology TP248.13-248.65 Medical technology R855-855.5 Cheng Ding Chuang Yang Tao Cheng Xingyan Wang Qiaojie Wang Renke He Shang Sang Kechao Zhu Dongdong Xu Jiaxing Wang Xijian Liu Xianlong Zhang Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis |
description |
Abstract Background Inflammatory osteolysis, a major complication of total joint replacement surgery, can cause prosthesis failure and necessitate revision surgery. Macrophages are key effector immune cells in inflammatory responses, but excessive M1-polarization of dysfunctional macrophages leads to the secretion of proinflammatory cytokines and severe loss of bone tissue. Here, we report the development of macrophage-biomimetic porous SiO2-coated ultrasmall Se particles (porous Se@SiO2 nanospheres) to manage inflammatory osteolysis. Results Macrophage membrane-coated porous Se@SiO2 nanospheres(M-Se@SiO2) attenuated lipopolysaccharide (LPS)-induced inflammatory osteolysis via a dual-immunomodulatory effect. As macrophage membrane decoys, these nanoparticles reduced endotoxin levels and neutralized proinflammatory cytokines. Moreover, the release of Se could induce macrophage polarization toward the anti-inflammatory M2-phenotype. These effects were mediated via the inhibition of p65, p38, and extracellular signal-regulated kinase (ERK) signaling. Additionally, the immune environment created by M-Se@SiO2 reduced the inhibition of osteogenic differentiation caused by proinflammation cytokines, as confirmed through in vitro and in vivo experiments. Conclusion Our findings suggest that M-Se@SiO2 have an immunomodulatory role in LPS-induced inflammation and bone remodeling, which demonstrates that M-Se@SiO2 are a promising engineered nanoplatform for the treatment of osteolysis occurring after arthroplasty. Graphical Abstract |
format |
article |
author |
Cheng Ding Chuang Yang Tao Cheng Xingyan Wang Qiaojie Wang Renke He Shang Sang Kechao Zhu Dongdong Xu Jiaxing Wang Xijian Liu Xianlong Zhang |
author_facet |
Cheng Ding Chuang Yang Tao Cheng Xingyan Wang Qiaojie Wang Renke He Shang Sang Kechao Zhu Dongdong Xu Jiaxing Wang Xijian Liu Xianlong Zhang |
author_sort |
Cheng Ding |
title |
Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis |
title_short |
Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis |
title_full |
Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis |
title_fullStr |
Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis |
title_full_unstemmed |
Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis |
title_sort |
macrophage-biomimetic porous se@sio2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/9b1124ab7b22439f9b6250b3c632546b |
work_keys_str_mv |
AT chengding macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT chuangyang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT taocheng macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT xingyanwang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT qiaojiewang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT renkehe macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT shangsang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT kechaozhu macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT dongdongxu macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT jiaxingwang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT xijianliu macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis AT xianlongzhang macrophagebiomimeticporoussesio2nanocompositesfordualmodalimmunotherapyagainstinflammatoryosteolysis |
_version_ |
1718407972051222528 |